New frontiers in metabolomics: From measurement to insight

Robert Powers, Eli Riekeberg

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Metabolomics is the newest addition to the "omics" disciplines and has shown rapid growth in its application to human health research because of fundamental advancements in measurement and analysis techniques. Metabolomics has unique and proven advantages in systems biology and biomarker discovery. The next generation of analysis techniques promises even richer and more complete analysis capabilities that will enable earlier clinical diagnosis, drug refinement, and personalized medicine. A review of current advancements in methodologies and statistical analysis that are enhancing and improving the performance of metabolomics is presented along with highlights of some recent successful applications.

Original languageEnglish (US)
Article number1148
JournalF1000Research
Volume6
DOIs
StatePublished - Jan 1 2017

Fingerprint

Metabolomics
Precision Medicine
Systems Biology
Biomarkers
Medicine
Early Diagnosis
Statistical methods
Health
Growth
Research
Pharmaceutical Preparations

Keywords

  • Biomarkers
  • Chemometrics
  • Dynamic Nuclear Polarization
  • Metabolomics
  • Metabonomics
  • Multiblock Analysis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

New frontiers in metabolomics : From measurement to insight. / Powers, Robert; Riekeberg, Eli.

In: F1000Research, Vol. 6, 1148, 01.01.2017.

Research output: Contribution to journalReview article

@article{131ef216436744749960b6ba0e6a8afe,
title = "New frontiers in metabolomics: From measurement to insight",
abstract = "Metabolomics is the newest addition to the {"}omics{"} disciplines and has shown rapid growth in its application to human health research because of fundamental advancements in measurement and analysis techniques. Metabolomics has unique and proven advantages in systems biology and biomarker discovery. The next generation of analysis techniques promises even richer and more complete analysis capabilities that will enable earlier clinical diagnosis, drug refinement, and personalized medicine. A review of current advancements in methodologies and statistical analysis that are enhancing and improving the performance of metabolomics is presented along with highlights of some recent successful applications.",
keywords = "Biomarkers, Chemometrics, Dynamic Nuclear Polarization, Metabolomics, Metabonomics, Multiblock Analysis",
author = "Robert Powers and Eli Riekeberg",
year = "2017",
month = "1",
day = "1",
doi = "10.12688/f1000research.11495.1",
language = "English (US)",
volume = "6",
journal = "F1000Research",
issn = "2046-1402",
publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - New frontiers in metabolomics

T2 - From measurement to insight

AU - Powers, Robert

AU - Riekeberg, Eli

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Metabolomics is the newest addition to the "omics" disciplines and has shown rapid growth in its application to human health research because of fundamental advancements in measurement and analysis techniques. Metabolomics has unique and proven advantages in systems biology and biomarker discovery. The next generation of analysis techniques promises even richer and more complete analysis capabilities that will enable earlier clinical diagnosis, drug refinement, and personalized medicine. A review of current advancements in methodologies and statistical analysis that are enhancing and improving the performance of metabolomics is presented along with highlights of some recent successful applications.

AB - Metabolomics is the newest addition to the "omics" disciplines and has shown rapid growth in its application to human health research because of fundamental advancements in measurement and analysis techniques. Metabolomics has unique and proven advantages in systems biology and biomarker discovery. The next generation of analysis techniques promises even richer and more complete analysis capabilities that will enable earlier clinical diagnosis, drug refinement, and personalized medicine. A review of current advancements in methodologies and statistical analysis that are enhancing and improving the performance of metabolomics is presented along with highlights of some recent successful applications.

KW - Biomarkers

KW - Chemometrics

KW - Dynamic Nuclear Polarization

KW - Metabolomics

KW - Metabonomics

KW - Multiblock Analysis

UR - http://www.scopus.com/inward/record.url?scp=85027246068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027246068&partnerID=8YFLogxK

U2 - 10.12688/f1000research.11495.1

DO - 10.12688/f1000research.11495.1

M3 - Review article

C2 - 28781759

AN - SCOPUS:85027246068

VL - 6

JO - F1000Research

JF - F1000Research

SN - 2046-1402

M1 - 1148

ER -